Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

1.

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Given with DTap Vaccine in Healthy Infants in Japan.

Togashi T, Okada K, Yamaji M, Thompson A, Gurtman A, Cutler M, Aizawa M, Gruber WC, Scott DA.

Pediatr Infect Dis J. 2015 Jun 26. [Epub ahead of print]

PMID:
26121200
2.
3.

Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.

Hibbs BF, Moro PL, Lewis P, Miller ER, Shimabukuro TT.

Vaccine. 2015 Jun 22;33(28):3171-8. doi: 10.1016/j.vaccine.2015.05.006. Epub 2015 May 14.

PMID:
25980429
4.

Surveillance of adverse events following vaccination in the French armed forces, 2011-2012.

Mayet A, Duron S, Meynard JB, Koeck JL, Deparis X, Migliani R.

Public Health. 2015 Jun;129(6):763-8. doi: 10.1016/j.puhe.2015.03.003. Epub 2015 Apr 15.

PMID:
25890634
5.

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants.

Scheifele DW, Ferguson M, Predy G, Dawar M, Assudani D, Kuriyakose S, Van Der Meeren O, Han HH.

Vaccine. 2015 Apr 15;33(16):1897-900. doi: 10.1016/j.vaccine.2015.02.015. Epub 2015 Feb 18.

6.

Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.

Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW.

Vaccine. 2015 Mar 24;33(13):1602-7. doi: 10.1016/j.vaccine.2015.02.008. Epub 2015 Feb 16.

PMID:
25698493
7.

[Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations].

Moreno-Pérez D, Álvarez García FJ, Arístegui Fernández J, Cilleruelo Ortega MJ, Corretger Rauet JM, García Sánchez N, Hernández Merino A, Hernández-Sampelayo Matos T, Merino Moína M, Ortigosa Del Castillo L, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP).

An Pediatr (Barc). 2015 Jan;82(1):44.e1-44.e12. doi: 10.1016/j.anpedi.2014.10.019. Spanish.

8.

Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™.

Leonardi M, Latiolais T, Sarpong K, Simon M, Twiggs J, Lei P, Rinderknecht S, Blatter M, Bianco V, Baine Y, Friedland LR, Baccarini C, Miller JM.

Vaccine. 2015 Feb 11;33(7):924-32. doi: 10.1016/j.vaccine.2014.09.064. Epub 2014 Oct 8.

10.

Vaccine safety implications of Ontario, Canada's switch from DTaP-IPV to Tdap-IPV for the pre-school booster.

Klar S, Harris T, Wong K, Fediurek J, Deeks SL.

Vaccine. 2014 Nov 12;32(48):6360-3. doi: 10.1016/j.vaccine.2014.09.017. Epub 2014 Sep 22.

PMID:
25252195
11.

Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age.

Marshall GS, Pool V, Greenberg DP, Johnson DR, Sheng X, Decker MD.

Clin Vaccine Immunol. 2014 Nov;21(11):1560-4. doi: 10.1128/CVI.00474-14. Epub 2014 Sep 17.

12.

Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.

Leonardi M, Latiolais T, Sarpong K, Simon M, Twiggs J, Lei P, Rinderknecht S, Blatter M, Bianco V, Baine Y, Friedland LR, Miller JM.

Vaccine. 2015 Feb 11;33(7):933-41. doi: 10.1016/j.vaccine.2014.08.027. Epub 2014 Aug 21.

13.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine manufactured with and without polysorbate 80 given to healthy infants at 2, 3, 4 and 12 months of age.

Gadzinowski J, Tansey SP, Wysocki J, Kopińska E, Majda-Stanisławska E, Czajka H, Korbal P, Pietrzyk JJ, Baker SA, Giardina PC, Gruber WC, Emini EA, Scott DA.

Pediatr Infect Dis J. 2015 Feb;34(2):180-5. doi: 10.1097/INF.0000000000000511.

PMID:
25126854
14.

Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience.

Reynolds DL, Vidor E.

Expert Rev Vaccines. 2014 Aug;13(8):943-68. doi: 10.1586/14760584.2014.933674. Epub 2014 Jul 2. Review.

PMID:
24985159
15.

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ.

JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633.

16.

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.

Vaccine. 2014 May 23;32(25):3019-24. doi: 10.1016/j.vaccine.2014.03.063. Epub 2014 Mar 31.

PMID:
24699471
17.

Booster vaccination: the role of reduced antigen content vaccines as a preschool booster.

Gabutti G, Trucchi C, Conversano M, Zivelonghi G, Zoppi G.

Biomed Res Int. 2014;2014:541319. doi: 10.1155/2014/541319. Epub 2014 Feb 11.

18.

Pertussis vaccine trials in the 1990s.

Lambert LC.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S4-9. doi: 10.1093/infdis/jit592. Review.

19.

Adverse Effects of Vaccines: Evidence and Causality.

Committee to Review Adverse Effects of Vaccines, Institute of Medicine; Stratton K, Ford A, Rusch E, Clayton EW, editors.

Washington (DC): National Academies Press (US); 2011 Aug 25.

20.

Hexavalent vaccines for immunization in paediatric age.

Esposito S, Tagliabue C, Bosis S, Ierardi V, Gambino M, Principi N.

Clin Microbiol Infect. 2014 May;20 Suppl 5:76-85. doi: 10.1111/1469-0691.12444. Epub 2014 Jan 24. Review.

PMID:
24460910
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk